Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lascoux

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of the International AIDS Society|April 1, 2017
Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort studyAnders Boyd, Julie Bottero, Patrick Miailhes, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2023
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected manMaud Salmona, Caroline Lascoux-Combe, Marie Laure Nere, et al.
Antiviral Therapy|November 21, 2007
Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapyOlivia Chauvel, Karine Lacombe, Philippe Bonnard, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2017
Infectious Zika virus in vaginal secretions from an HIV-infected woman, France, August 2016Pauline Penot, Ségolène Brichler, Jean Guilleminot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2009
Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?Firouzé Bani-Sadr, Pierre Bedossa, Eric Rosenthal, et al.
Journal of Hepatology|May 24, 2016
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patientsAnders Boyd, Karine Lacombe, Fabien Lavocat, et al.
AIDS (London, England)|March 3, 2006
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAnne Bourgarit, Guislaine Carcelain, Valerie Martinez, et al.
AIDS (London, England)|October 20, 2011
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies useRosemary Dray-Spira, Camille Legeai, Mariette Le Den, et al.
Hepatology International|July 16, 2011
Current management and recommendations on hepatitis B therapy in HIV-coinfected patientsLionel Piroth, Sophie Mahy, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|March 8, 2013
High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patientsKarine Lacombe, Anders Boyd, Fabien Lavocat, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of the International AIDS Society|April 1, 2017
Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort studyAnders Boyd, Julie Bottero, Patrick Miailhes, et al.
The Journal of Antimicrobial Chemotherapy|May 6, 2023
Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected manMaud Salmona, Caroline Lascoux-Combe, Marie Laure Nere, et al.
Antiviral Therapy|November 21, 2007
Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapyOlivia Chauvel, Karine Lacombe, Philippe Bonnard, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 28, 2017
Infectious Zika virus in vaginal secretions from an HIV-infected woman, France, August 2016Pauline Penot, Ségolène Brichler, Jean Guilleminot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2009
Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?Firouzé Bani-Sadr, Pierre Bedossa, Eric Rosenthal, et al.
Journal of Hepatology|May 24, 2016
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patientsAnders Boyd, Karine Lacombe, Fabien Lavocat, et al.
AIDS (London, England)|March 3, 2006
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAnne Bourgarit, Guislaine Carcelain, Valerie Martinez, et al.
AIDS (London, England)|October 20, 2011
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies useRosemary Dray-Spira, Camille Legeai, Mariette Le Den, et al.
Hepatology International|July 16, 2011
Current management and recommendations on hepatitis B therapy in HIV-coinfected patientsLionel Piroth, Sophie Mahy, Stanislas Pol, et al.
Hepatology (Baltimore, Md.)|March 8, 2013
High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patientsKarine Lacombe, Anders Boyd, Fabien Lavocat, et al.
Pageof 8